Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label L-arginine Phase III trial for interictal phase of stroke-like episodes in MELAS
jRCT1091220025Phase 3Completed
- Sponsor
- Kurume University School of Medicine
- Start
- Mar 2009
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of arginine in mitochondrial encephalomyopathies, sponsored by Kurume University School of Medicine. Primary endpoint: MELAS stroke scale. Started Mar 2009; status: completed.
02
Drugs
arginine
03
Conditions
mitochondrial encephalomyopathies
Beyond the preview
Go deeper on jRCT1091220025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220025.